| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |